Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
FEMALE
ID07566949

Manchester Procedure Versus Vaginal Hysterectomy for Women With Uterine Prolapse: A Multi-Center Randomized Controlled Study (The Fin-UP Trial)

Led by Tampere University Hospital · Updated on 2026-05-11

426

Participants Needed

6

Research Sites

417 weeks

Total Duration

On this page

Sponsors

T

Tampere University Hospital

Lead Sponsor

H

Helsinki University Central Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to compare two surgical treatments for women with symptomatic uterine prolapse, a condition where pelvic organs descend and affect quality of life. The trial evaluates the Manchester procedure, a uterus-preserving surgery, against vaginal hysterectomy, which removes the uterus and has been the standard treatment. The study focuses on success rates at two years post-operation and includes long-term follow-up to better understand patient outcomes. Participants are randomly assigned to either the Manchester procedure or vaginal hysterectomy group. The Manchester procedure involves modifying and suturing the cervix and surrounding ligaments while preserving the uterus, along with repairing other pelvic areas if needed. Vaginal hysterectomy involves removing the uterus through the vagina, suspending pelvic ligaments, and repairing additional pelvic defects as indicated. Both groups may receive further repairs such as anterior and posterior colporrhaphy and perineorrhaphy. Follow-up visits are scheduled at 2 and 5 years, with questionnaires completed at 1, 2, 5, and 10 years after surgery. During the study, participants will undergo clinical examinations, ultrasound assessments, and complete detailed questionnaires addressing pelvic symptoms, quality of life, sexual function, and satisfaction. Researchers will measure treatment success by the absence of prolapse beyond the hymen, lack of bulge symptoms, and no need for retreatment. Other outcomes include adverse events, surgery details like blood loss and operating time, and long-term complications. The study spans up to 10 years of follow-up, providing valuable data on the effectiveness and safety of both surgical options.

CONDITIONS

Brief Title

The Finnish Uterine Prolapse Surgery Trial (The Fin-UP Trial)

Who Can Participate

Age: 18Years - 100Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Fit for elective vaginal surgery according to standard preoperative assessment
  • Women aged over 18 years
  • No previous pelvic organ prolapse surgery
  • Symptomatic pelvic organ prolapse stage 2 or higher, with uterine descent of at least stage 2 (POP-Q point C 65 minus 1) and with POP-Q point D 64 minus 1
  • Patients with concurrent anterior or posterior compartment defects are included
Not Eligible

You will not qualify if you...

  • Pregnancy or future plans of pregnancy
  • Active malignancy of any kind
  • Contraindications for uterine preservation such as suspected cervical or uterine malignancy, abnormal cervical cytology, abnormal uterine bleeding, history of endometrial hyperplasia with atypia, or known hereditary cancer syndrome involving the uterus
  • Contraindication to vaginal hysterectomy, for example, extensive intra-abdominal adhesions
  • Patient preference for uterine removal or preservation
  • Planned concomitant incontinence procedure
  • Inability to speak Finnish or Swedish, understand the study purpose, or commit to follow-up

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Days from operation to discharge

Participants undergo either the Manchester procedure or vaginal hysterectomy surgery to treat uterine prolapse. This stage includes surgery and immediate recovery care.

1 perioperative visit

Post-operative Follow-up

Duration - Up to 2 months after surgery

Participants are followed up to monitor recovery, assess surgical outcomes, and evaluate pelvic floor symptoms, quality of life, and adverse events.

Visits at 1 and 2 months post-operation

Long-term Monitoring

Duration - Up to 10 years

Participants are monitored long-term to assess surgical success, symptom improvement, reoperation rates, and quality of life at multiple timepoints.

Visits at 1, 2, 5, and 10 years post-surgery

Trial Site Locations

Total: 6 locations

1

Helsinki University Hospital

Helsinki, Finland

Actively Recruiting

2

Hospital Nova, The Wellbeing Services County of Central Finland

Jyväskylä, Finland

Actively Recruiting

3

Kuopio University Hospital

Kuopio, Finland

Actively Recruiting

4

Oulu University Hospital

Oulu, Finland

Actively Recruiting

5

Tampere University Hospital

Tampere, Finland

Actively Recruiting

6

Turku University Hospital

Turku, Finland

Actively Recruiting

Loading map...

Research Team

P

Päivi K Karjalainen, MD, PhD

A

Anniina Karioja, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Accelerometer Measured Early Recovery After Prolapse Surgery...

Pelvic Organ Prolapse

Actively Recruiting

7 locations

Energy-based Opportunistic Salpingo-oophorectomy During Vagi...

Pelvic Organ Prolapse (POP)

Actively Recruiting

1 location

Development and Validation of a Risk Prediction Model for De...

Pelvic Organ Prolapse (POP)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here